Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
RYAN DEFFENBAUGH

IBD Stock Of The Day: AMD Surges After Rolling Out New AI Chip To Challenge Nvidia

Advanced Micro Devices is the IBD Stock of the Day for Thursday as AMD stock surges back above a cup-with-handle buy point with significant trading volume. AMD on Wednesday unveiled a line of chips optimized for artificial intelligence, challenging AI kingpin Nvidia in a red-hot market.

Reaction from investors was muted Wednesday after AMD launched its Instinct MI300X line of accelerators. But AMD stock rallied 9.9% to close at 128.37 on the stock market today. AMD previewed the chips in June and there were no major surprises Wednesday. AMD also faces a long road to challenging Nvidia. But analysts were positive on AMD following the event.

"We think part of what makes a good stock is the ability to dream — and this certainly fits the bill as AMD is still a fairly small company in very large markets," UBS analyst Timothy Arcuri wrote in a note to clients late Wednesday.

AMD Stock: Challenging Nvidia

Santa Clara, Calif.-based AMD competes with Intel in making central processing units, or CPUs, for personal computers and servers. But the firm is also a challenger to Nvidia in the market for graphics processing units, or GPUs, for PCs, gaming consoles and data centers.

At AMD's event Wednesday, AMD Chief Executive Lisa Su said the firm's newest chips offer industry-leading capacity and bandwidth. She portrayed AMD as well-positioned to handle the rapid growth of generative artificial intelligence products, sparked by the launch of OpenAI's ChatGPT last year. So far, Nvidia's H100 chip has dominated the lucrative market of powering AI applications.

The event kicked off AMD's most significant effort yet to win part of that spending. During its Oct. 31 earnings call with analysts, AMD officials projected $2 billion in 2024 sales for the MI300x accelerators.

The company did not provide an upgrade to those estimates Wednesday to the disappointment of some analysts. But Raymond James analyst Srini Pajjuri says he sees room for upside for the target.

"Longer term, we see no reason why AMD cannot capture 10-20% share in the Gen AI accelerator market, which should drive double-digit top-line growth and margin expansion for the next 2–3 years," Pajjuri wrote Wednesday.

Microsoft, Meta, Oracle Ready As Partners

AMD's event featured appearances from executives with Microsoft, Meta  and Oracle. The companies each said they are using the chips.

"Key customers included Microsoft, Oracle, and Meta but this was largely expected, as primary hyperscalers work to integrate a second source," wrote Barclays analyst Tom O'Malley in a client note Wednesday. "MI300X will also be supported in OpenAI's Triton 3.0 launch, their open-source programming language for AI, which should help bridge some of the software gap."

The event did not feature appearances from cloud service providers Amazon and Google parent company Alphabet. But "we won't rule them out as future customers for Instinct GPUs given AMD's strong existing relationships and its execution track record," wrote Pajjuri for Raymond James.

AMD Stock: Chasing $400 Billion Market

While AMD did not update its sales forecast, it did provide updated estimates on the total market. AMD projects spending will surge 70% annually to reach more than $400 billion in 2027. That's up from a previous projection of $150 billion.

Still, AMD has a lot of work ahead in challenging Nvidia. Last quarter, Nvidia recorded $18 billion in sales, compared to AMD's $5.8 billion. NVDA stock has gained 213% this year compared to a more modest but still impressive 94% for AMD stock.

AMD's "$400 billion+ estimate may prove extremely bullish/optimistic, but would probably be even more bullish for NVDA should such a thing actually comes to pass," Bernstein analyst Stacy Rasgon wrote in a client note Thursday.

Still, analysts see AMD as benefiting from growing AI spending.

"Overall, the event did a better job of focusing on the growth of the AI industry, which should inherently help AMD as the pie grows," O'Malley, the Barclays analyst, wrote.

AMD's sales projection of $2 billion "is still a substantial ramp but we would expect the company to revise higher as the year progresses, largely as a function of an ecosystem desperate for a second source," he added.

Futures: Two AI Giants Lead Rally With Jobs Report Due

AMD Stock: Back Above Buy Point

With its gains Thursday, AMD stock jumped back above a $122.11 buy point for a cup-with-handle base on its daily chart, according to IBD MarketSmith.

Meanwhile, AMD stock's Relative Strength Rating of 91 out of 99 is at its highest point since mid-June. The Relative Strength Rating shows how a stock's price performance stacks up against all other stocks over the last 52 weeks. The best growth stocks typically have RS Ratings of at least 80.

Further, AMD ranks second among 37 stocks in IBD's fabless semiconductor industry group, according to IBD Stock Checkup. NVDA is the top stock in the group.

AMD stock carries an IBD Composite Rating of 90 out of 99. IBD's Composite Rating combines five separate proprietary ratings into one rating. The best growth stocks have a Composite Rating of 90 or better.

Further, AMD stock is on the IBD Tech Leaders list.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.